These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16030019)

  • 1. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Breyer RM
    J Biol Chem; 2005 Sep; 280(37):32442-51. PubMed ID: 16030019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Marnett LJ; Breyer RM
    Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
    Sugimoto H; Shichijo M; Okano M; Bacon KB
    Eur J Pharmacol; 2005 Nov; 524(1-3):30-7. PubMed ID: 16256979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and molecular pharmacology of the mouse CRTH2 receptor.
    Hata AN; Zent R; Breyer MD; Breyer RM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
    Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
    J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
    Xue L; Salimi M; Panse I; Mjösberg JM; McKenzie AN; Spits H; Klenerman P; Ogg G
    J Allergy Clin Immunol; 2014 Apr; 133(4):1184-94. PubMed ID: 24388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2.
    Hirai H; Tanaka K; Takano S; Ichimasa M; Nakamura M; Nagata K
    J Immunol; 2002 Feb; 168(3):981-5. PubMed ID: 11801628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.
    Gallant MA; Slipetz D; Hamelin E; Rochdi MD; Talbot S; de Brum-Fernandes AJ; Parent JL
    Eur J Pharmacol; 2007 Feb; 557(2-3):115-23. PubMed ID: 17207480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
    Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
    Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
    Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
    Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel PGD(2) receptor expressed in eosinophils.
    Powell WS
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):179-85. PubMed ID: 12895601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
    Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
    J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.
    Nagata K; Hirai H
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):169-77. PubMed ID: 12895600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for lipid recognition by the prostaglandin D
    Liu H; Deepak RNVK; Shiriaeva A; Gati C; Batyuk A; Hu H; Weierstall U; Liu W; Wang L; Cherezov V; Fan H; Zhang C
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34341104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2.
    Sawyer N; Cauchon E; Chateauneuf A; Cruz RP; Nicholson DW; Metters KM; O'Neill GP; Gervais FG
    Br J Pharmacol; 2002 Dec; 137(8):1163-72. PubMed ID: 12466225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of DP and CRTH2 in allergic inflammation.
    Kostenis E; Ulven T
    Trends Mol Med; 2006 Apr; 12(4):148-58. PubMed ID: 16545607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.
    Mathiesen JM; Ulven T; Martini L; Gerlach LO; Heinemann A; Kostenis E
    Mol Pharmacol; 2005 Aug; 68(2):393-402. PubMed ID: 15870392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
    Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
    J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a potent and selective synthetic agonist at the CRTH2 receptor.
    Gervais FG; Morello JP; Beaulieu C; Sawyer N; Denis D; Greig G; Malebranche AD; O'Neill GP
    Mol Pharmacol; 2005 Jun; 67(6):1834-9. PubMed ID: 15755909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling.
    Choi YH; Lee SN; Aoyagi H; Yamasaki Y; Yoo JY; Park B; Shin DM; Yoon HG; Yoon JH
    J Biol Chem; 2011 Sep; 286(39):34199-214. PubMed ID: 21832046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.